The University of Michigan is now conducting two studies in partnership with Dr. Sue Sisley MD, President/Principal Investigator of Scottsdale Research Institute.
The purpose of both studies is to understand how medical cannabis use among patients with chronic pain affects pain management, quality of life, and the use of other medications.
The information you provide will help inform physicians, researchers, policy-makers, and patients about potential benefits and risks of cannabis as a therapeutic or recreational agent.
Study 1:
In this study, you will be asked to complete an online anonymous, confidential survey.
Eligibility:
Anyone who uses cannabis for chronic pain and has a medical cannabis license OR who uses cannabis medically in a state with recreational cannabis can participate by clicking this link.
The password is UMsurvey.
Study 2:
In this study, you will be asked to complete online anonymous, confidential surveys at baseline (within the next week), as well as 3, 6, 9, and 12 months after the initial survey.
Study participants will be compensated after completing each survey: $10 after the first survey, and $10 after each follow-up survey.
Eligibility:
You are eligible to participate in this study if all the conditions below are met:
1. You are 18 years of age or older.
2. You have a medical cannabis certification in your state of residence.
3. You either have been using cannabis for chronic pain main management for less than six months OR you plan to but have not started using cannabis for chronic pain management.
If you think you will not be able to participate at all follow-up points, please do NOT participate in this survey.
If you fulfill all these criteria and are interested in participating, please contact Dr. Kevin Boehnke PhD at [email protected].
